drugset / Trial / NCT03240445

Impact of Changing the Dosing Regimen on the PK Profile of ODM-203

NCT03240445 ↗

RandomizedCrossoverOpen-labelOther

Summary

This Phase I study in healthy male volunteers will evaluate the impact of the effect of food on the pharmacokinetic profile of ODM-203.

Timeline

Start
2017-08-24
Primary completion
2017-10-23
Completion
2017-10-23

Drugs

EvaluationDrugModalityDoseRoute
Subject ODM-203 Unknown 400 mg Oral

Indications

No indication recorded.